Sanofi
SNY
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, otā¦ read more
Healthcare
Drug ManufacturersāGeneral
23 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$49.84
Price+0.14%
$0.07
1Y
Price
Market Cap
$123.548b
Large
Price/Earnings 3y Avg5y Avg
16.5x
Premium
Premium
Financials Overview
Key metrics over the past few years+17.6%
EBITDA Margin+36.7%
Net Profit Margin+19.5%
Free Cash Flow MarginRevenue
$43.129b
-2.6%
1y CAGR-1.7%
3y CAGR+2.7%
5y CAGREarnings
$9.126b
+64.1%
1y CAGR+10.5%
3y CAGR+16.5%
5y CAGREPS
$2.16
-6.1%
1y CAGR-6.4%
3y CAGR-2.8%
5y CAGRBook Value
$70.279b
$124.959b
Assets$54.680b
Liabilities$22.285b
DebtDebt to Assets
17.8%
2.3x
Debt to EBITDAFree Cash Flow
$1.589b
-73.0%
1y CAGR-34.9%
3y CAGR-26.6%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in EUR.No items found.
Press Releases
Statements and updates from the company